School of Medicine
Showing 9,111-9,120 of 12,915 Results
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatology
BioDr Nilima Ragavan is a Neonatologist and Clinical Professor at the Stanford University School of Medicine. She is an experienced clinician who has expertise in the care of critically ill newborns.She is the Neonatal Outreach Medical director for Stanford Children's health, Co director of the Mid Coastal California Perinatal Outreach Program, and the Medical director of the Special care Nursery at Stanford Children's Health.She serves as a mentor to junior faculty. Dr Ragavan is passionate about education, and social justice. She has worked in and promoted social organizations in the fields of education, health care, livelihood and women's empowerment in India.She founded a group called Teach to Heal to promote cross cultural education and has led several multidisciplinary medical teams to India, as well as organized and conducted international neonatal and perinatal conferences.
-
Amer Raheemullah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences at Stanford University and a Consultant Physician in Addiction Medicine. He is the Director of Stanford Hospital Addiction Services (shas.stanford.edu), which he initially launched at a single site, and after demonstrating significant improvements in patient outcomes, led its expansion across Stanford’s multiple hospital sites.
His research and insights on addiction medicine have been published in leading journals including JAMA and Cambridge University Press, and has been featured in media outlets such as Bloomberg News, ABC7 News, KQED, and Everyday Health. He also consults for various Silicon Valley digital health startups focused on addiction treatment, such as Lucid Lane, where he designed the clinical programs that enabled the organization to scale from a single state to a national telehealth platform operating across most of the United States. He has been invited to advise on national addiction policy by government agencies including the U.S. Food and Drug Administration (FDA), the U.S. Department of Health and Human Services (HHS), the Substance Abuse and Mental Health Services Administration (SAMHSA), as well as the Congress-established Reagan-Udall Foundation.
He completed his addiction medicine training at Stanford University School of Medicine and is board certified in addiction medicine and internal medicine. His work focuses on translating research into scalable models of addiction treatment and helping health systems implement high-quality, evidence-based care.
